Opening book details…
About this Medicine article
Final Overall Survival Results from a Phase 3 Study to Compare Tivozanib to Sorafenib as Third- or Fourth-line Therapy in Subjects with Metastatic Renal Cell Carcinoma by Pal, Sumanta K.; Escudier, Bernard J.; Atkins, Michael B.; Hutson, Thomas E.; Porta, Camillo; Verzoni, Elena; Needle, Michael N.; Powers, Daniel; McDermott, David F.; Rini, Brian I. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Pal, Sumanta K.; Escudier, Bernard J.; Atkins, Michael B.; Hutson, Thomas E.; Porta, Camillo; Verzoni, Elena; Needle, Michael N.; Powers, Daniel; McDermott, David F.; Rini, Brian I.
- Publisher
- Elsevier Science; Elsevier ; Elsevier BV (ISSN 0302-2838)
- Published
- 2020
- Field
- Medicine (Health Sciences)